{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:09:13Z","timestamp":1785434953144,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.tice.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T08:28:47Z","timestamp":1569054527000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse model"],"prefix":"10.1016","volume":"61","author":[{"given":"Jun Ho","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Nam","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Sugisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Clary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree Ram","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2019.09.006_bib0005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/15384101.2016.1271635","article-title":"The new anticancer era: tumor metabolism targeting","volume":"16","author":"Borriello","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tice.2019.09.006_bib0010","first-page":"283","article-title":"Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens","volume":"13","author":"Fu","year":"1993","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tice.2019.09.006_bib0015","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.21873\/anticanres.12899","article-title":"Oral Recombinant Methioninase Combined with Caffeine and Doxorubicin Induced Regression of a Doxorubicin-resistant Synovial Sarcoma in a PDOX Mouse Model","volume":"38","author":"Higuchi","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tice.2019.09.006_bib0020","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.21873\/anticanres.13646","article-title":"Oral Recombinant Methioninase, Combined With Oral Caffeine and Injected Cisplatinum, Overcome Cisplatinum-Resistance and Regresses Patient-derived Orthotopic Xenograft Model of Osteosarcoma","volume":"39","author":"Higuchi","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tice.2019.09.006_bib0025","doi-asserted-by":"crossref","first-page":"e114310","DOI":"10.1371\/journal.pone.0114310","article-title":"Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore","volume":"9","author":"Hiroshima","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tice.2019.09.006_bib0030","doi-asserted-by":"crossref","first-page":"e0134324","DOI":"10.1371\/journal.pone.0134324","article-title":"Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice","volume":"10","author":"Hiroshima","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tice.2019.09.006_bib0035","first-page":"49","article-title":"Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis","volume":"738","author":"Hoffman","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tice.2019.09.006_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1517\/14712598.2015.963050","article-title":"Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey","volume":"15","author":"Hoffman","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.tice.2019.09.006_bib0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrc3972","article-title":"Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts","volume":"15","author":"Hoffman","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tice.2019.09.006_bib0050","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/15384101.2017.1304330","article-title":"The wayward methyl group and the cascade to cancer","volume":"16","author":"Hoffman","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tice.2019.09.006_bib0055","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/15384101.2018.1431596","volume":"17","author":"Igarashi","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tice.2019.09.006_bib0060","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/jcb.26527","article-title":"Growth of doxorubicin-resistant undifferentiated spindle-cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninase","volume":"119","author":"Igarashi","year":"2018","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.tice.2019.09.006_bib0065","doi-asserted-by":"crossref","first-page":"71737","DOI":"10.18632\/oncotarget.12328","article-title":"Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse model","volume":"7","author":"Kawaguchi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2019.09.006_bib0070","doi-asserted-by":"crossref","first-page":"85516","DOI":"10.18632\/oncotarget.20231","article-title":"Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model","volume":"8","author":"Kawaguchi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2019.09.006_bib0075","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/jcb.25886","article-title":"Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model","volume":"118","author":"Kawaguchi","year":"2017","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.tice.2019.09.006_bib0080","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/15384101.2017.1405195","article-title":"Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention","volume":"17","author":"Kawaguchi","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tice.2019.09.006_bib0085","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.bbrc.2018.08.097","article-title":"Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma","volume":"503","author":"Kawaguchi","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tice.2019.09.006_bib0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.18632\/oncotarget.23185","article-title":"Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models","volume":"9","author":"Kawaguchi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2019.09.006_bib0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.canlet.2018.06.016","article-title":"Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer","volume":"432","author":"Kawaguchi","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tice.2019.09.006_bib0100","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/15384101.2018.1445907","article-title":"Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer","volume":"17","author":"Kawaguchi","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tice.2019.09.006_bib0105","doi-asserted-by":"crossref","first-page":"33046","DOI":"10.18632\/oncotarget.8848","article-title":"High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model","volume":"7","author":"Kiyuna","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2019.09.006_bib0110","first-page":"1866","article-title":"Biological effects of enzymatic deprivation of L-methionine in cell culture and an experimental tumor","volume":"33","author":"Kreis","year":"1973","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2019.09.006_bib0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-019-0198-5","article-title":"A framework for examining how diet impacts tumour metabolism","author":"Lien","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tice.2019.09.006_bib0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jso.23507","article-title":"Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model","volume":"109","author":"Metildi","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.tice.2019.09.006_bib0125","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/jor.22706","article-title":"Fluorescence-guided surgery improves outcome in an orthotopic osteosarcoma nude-mouse model","volume":"32","author":"Miwa","year":"2014","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.tice.2019.09.006_bib0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jss.2014.05.049","article-title":"Fluorescence-guided surgery of prostate cancer bone metastasis","volume":"192","author":"Miwa","year":"2014","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.tice.2019.09.006_bib0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jor.22973","article-title":"Fluorescence-guided surgery of human prostate cancer experimental bone metastasis in nude mice using anti-CEA DyLight 650 for tumor illumination","volume":"34","author":"Miwa","year":"2016","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.tice.2019.09.006_bib0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000495574","article-title":"Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing\u2019s Sarcoma in a Patient-Derived Orthotopic Xenograft Model","volume":"63","author":"Miyake","year":"2018","journal-title":"Chemotherapy"},{"key":"10.1016\/j.tice.2019.09.006_bib0145","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.bbrc.2019.01.046","article-title":"Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model","volume":"509","author":"Miyake","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tice.2019.09.006_bib0150","doi-asserted-by":"crossref","first-page":"12783","DOI":"10.18632\/oncotarget.7226","article-title":"Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model","volume":"7","author":"Murakami","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2019.09.006_bib0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jn\/123.2.269","article-title":"Low methionine ingestion by rats extends life span","volume":"123","author":"Orentreich","year":"1993","journal-title":"J Nutr"},{"key":"10.1016\/j.tice.2019.09.006_bib0160","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.21873\/anticanres.13648","article-title":"Oral recombinant methioninase overcomes colorectal-cancer liver metastasis resistance to the combination of 5-Fluorouracil and oxaliplatinum in a patient-derived orthotopic xenograft mouse model","volume":"39","author":"Oshiro","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tice.2019.09.006_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2019.08.051","article-title":"Efficacy of oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil on primary colon cancer in a patient-derived orthotopic xenograft mouse model","author":"Park","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tice.2019.09.006_bib0170","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.21873\/anticanres.13492","article-title":"Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells","volume":"39","author":"Park","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tice.2019.09.006_bib0175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF02619617","article-title":"Elevated overall rates of transmethylation in cell lines from diverse human tumors","volume":"20","author":"Stern","year":"1984","journal-title":"In Vitro"},{"key":"10.1016\/j.tice.2019.09.006_bib0180","first-page":"3063","article-title":"Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer-patient tumorgraft progression in nude mice","volume":"32","author":"Suetsugu","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tice.2019.09.006_bib0185","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0003-9861(59)90225-5","article-title":"Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid","volume":"81","author":"Sugimura","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tice.2019.09.006_bib0190","first-page":"1041","article-title":"Broad selective efficacy of recombinant methioninase and polyethylene glycol-modified recombinant methioninase on cancer cells In Vitro","volume":"30","author":"Tan","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tice.2019.09.006_bib0195","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ijc.2910510626","article-title":"A new patient-like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice","volume":"51","author":"Wang","year":"1992","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tice.2019.09.006_bib0200","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41591-019-0423-5","article-title":"Methionine is a metabolic dependency of tumor-initiating cells","volume":"25","author":"Wang","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tice.2019.09.006_bib0205","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1166\/jnn.2013.6881","article-title":"Stealth cationic liposomes modified with anti-CAGE single-chain fragment variable deliver recombinant methioninase for gastric carcinoma therapy","volume":"13","author":"Xin","year":"2013","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.tice.2019.09.006_bib0210","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171001","article-title":"Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma","volume":"38","author":"Xin","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.tice.2019.09.006_bib0215","doi-asserted-by":"crossref","first-page":"91030","DOI":"10.18632\/oncotarget.19024","article-title":"The performance of 11C-Methionine PET in the differential diagnosis of glioma recurrence","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2019.09.006_bib0220","doi-asserted-by":"crossref","first-page":"e0160882","DOI":"10.1371\/journal.pone.0160882","article-title":"Efficacy of tumor-targeting Salmonella A1-R on a melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse model","volume":"11","author":"Yamamoto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tice.2019.09.006_bib0225","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.4161\/15384101.2014.964115","article-title":"Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy","volume":"13","author":"Yano","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tice.2019.09.006_bib0230","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1080\/15384101.2016.1181240","article-title":"Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging","volume":"15","author":"Yano","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tice.2019.09.006_bib0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0531-5565(02)00149-3","article-title":"Nutritional control of aging","volume":"38","author":"Zimmerman","year":"2003","journal-title":"Exp. Gerontol."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816619302460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816619302460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:18:31Z","timestamp":1758572311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816619302460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":47,"alternative-id":["S0040816619302460"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2019.09.006","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse model","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}